IL126484A0 - Il-6 mutein - Google Patents

Il-6 mutein

Info

Publication number
IL126484A0
IL126484A0 IL12648497A IL12648497A IL126484A0 IL 126484 A0 IL126484 A0 IL 126484A0 IL 12648497 A IL12648497 A IL 12648497A IL 12648497 A IL12648497 A IL 12648497A IL 126484 A0 IL126484 A0 IL 126484A0
Authority
IL
Israel
Prior art keywords
mutein
diseases
auotoimmune
plasmocytoma
neoplastic
Prior art date
Application number
IL12648497A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL126484A0 publication Critical patent/IL126484A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Details Of Television Scanning (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Amplifiers (AREA)
IL12648497A 1996-04-09 1997-04-08 Il-6 mutein IL126484A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN96180247A CN1131309C (zh) 1996-04-09 1996-04-09 白细胞介素－6突变蛋白
CA002251355A CA2251355C (en) 1996-04-09 1996-04-09 Il-6 mutein
PCT/EP1996/001506 WO1997038103A1 (en) 1996-04-09 1996-04-09 Il-6 mutein
PCT/EP1997/001736 WO1997038104A1 (en) 1996-04-09 1997-04-08 Il-6 mutein

Publications (1)

Publication Number Publication Date
IL126484A0 true IL126484A0 (en) 1999-08-17

Family

ID=27170853

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12648497A IL126484A0 (en) 1996-04-09 1997-04-08 Il-6 mutein

Country Status (18)

Country Link
US (1) US6280975B1 (de)
EP (1) EP0907737B1 (de)
JP (1) JP4189866B2 (de)
CN (1) CN1131309C (de)
AT (1) ATE291087T1 (de)
AU (1) AU728267B2 (de)
BR (1) BR9708648B1 (de)
CA (1) CA2251355C (de)
DE (1) DE69634497T2 (de)
DK (1) DK0907737T3 (de)
EA (1) EA000852B1 (de)
ES (1) ES2238690T3 (de)
FI (1) FI982198A0 (de)
IL (1) IL126484A0 (de)
NO (1) NO322479B1 (de)
PT (1) PT907737E (de)
UA (1) UA72426C2 (de)
WO (2) WO1997038103A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723319B1 (en) * 1998-03-17 2004-04-20 Chugai Seiyaku Kabushiki Kaisha Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies
KR20060119412A (ko) * 2005-05-20 2006-11-24 아주대학교산학협력단 ＩＬ-6 발현 억제를 위한 ｓｉＲＮＡ 및 이를 함유하는조성물
US8522915B2 (en) * 2007-12-19 2013-09-03 Westerngeco L.L.C. Method and system for selecting parameters of a seismic source array
CN102101885B (zh) * 2010-09-01 2013-06-05 南京发士达生物科技有限公司 低诱导抑制性t细胞的人白细胞介素ⅱ突变体及其用途

Also Published As

Publication number Publication date
EP0907737A1 (de) 1999-04-14
EA000852B1 (ru) 2000-06-26
AU5686496A (en) 1997-10-29
US6280975B1 (en) 2001-08-28
HK1019770A1 (en) 2000-02-25
WO1997038103A1 (en) 1997-10-16
FI982198A7 (fi) 1998-10-09
DK0907737T3 (da) 2005-06-27
CN1216063A (zh) 1999-05-05
BR9708648A (pt) 1999-08-03
JP2000508164A (ja) 2000-07-04
EA199800914A1 (ru) 1999-04-29
FI982198L (fi) 1998-10-09
ES2238690T3 (es) 2005-09-01
CN1131309C (zh) 2003-12-17
NO984697D0 (no) 1998-10-08
BR9708648B1 (pt) 2011-02-08
JP4189866B2 (ja) 2008-12-03
NO984697L (no) 1998-10-08
WO1997038104A1 (en) 1997-10-16
UA72426C2 (en) 2005-03-15
CA2251355A1 (en) 1997-10-16
FI982198A0 (fi) 1998-10-09
DE69634497D1 (de) 2005-04-21
EP0907737B1 (de) 2005-03-16
ATE291087T1 (de) 2005-04-15
CA2251355C (en) 2009-06-09
DE69634497T2 (de) 2006-01-26
AU728267B2 (en) 2001-01-04
PT907737E (pt) 2005-05-31
NO322479B1 (no) 2006-10-09

Similar Documents

Publication Publication Date Title
MXPA02008233A (es) Compuestos de pteridina para tratamiento de psoriasis.
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
MX9703546A (es) Benzotiazepinas hipolipidemicas.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
MXPA04004552A (es) Compuestos tipo indolizina sustituida y metodos de uso.
MX9702932A (es) L-ribofuranosilnucleosidos.
GB0111186D0 (en) Novel compounds
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
MXPA02006610A (es) Sustancias para uso al tratar psoriasis.
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
DE69814109D1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
FR2651435B1 (de)
GB2331926A (en) Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
IL126484A0 (en) Il-6 mutein
ATE254595T1 (de) 2-amino-6-methyl-7-acetyl-tetralin und pharmazeutische zusammensetzungen zur vorbeugung und therapeutischen behandlung von entzündlichen und/oder autoimmunkrankheiten
BR0212249A (pt) Composto, composição farmacêutica, método de tratamento ou profilaxia de doenças, e, uso de um composto
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
IL132354A0 (en) Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
NZ319571A (en) Process for purifying alkoxylated fats
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed